Neurology Drugs Advertised on TV

16 prescription neurology medications seen in TV advertising, ranked by estimated annual ad spend.

Share

Information reviewed July 24, 2026

US Nurtec ODT

rimegepant · Migraine (acute and preventive)

US Ubrelvy

ubrogepant · Acute migraine

US Austedo

deutetrabenazine · Tardive dyskinesia, Huntington's chorea

US Qulipta

atogepant · Migraine prevention

US Emgality

galcanezumab · Migraine prevention, cluster headache

US Aimovig

erenumab · Migraine prevention

US Ajovy

fremanezumab · Migraine prevention

US Gabapentin

gabapentin · Nerve pain, seizures

US Leqembi

lecanemab · Early Alzheimer's disease

US Vyepti

eptinezumab · Migraine prevention

US Botox

onabotulinumtoxinA · Chronic migraine

US Ingrezza

valbenazine · Tardive dyskinesia

US Ocrevus

ocrelizumab · Multiple sclerosis

US Kesimpta

ofatumumab · Multiple sclerosis

US Vyvgart

efgartigimod alfa · Generalized myasthenia gravis

US Kisunla

donanemab · Early Alzheimer's disease

Popular comparisons

Frequently asked questions

What neurology drugs are advertised on TV?

Nurtec ODT, Ubrelvy, Austedo, Qulipta, Emgality and 11 more are among the neurology medications currently advertised on television. TVPills tracks 16 of them.

Which neurology drug spends the most on TV advertising?

Nurtec ODT (rimegepant) leads with an estimated $190M in annual TV ad spend.

Which neurology medication is right for me?

TVPills is an informational reference, not medical advice. Only a licensed healthcare provider can recommend the right neurology treatment for your situation.

TVPills

A reference tool to help identify prescription medications and supplements seen in television advertising. This is not medical advice. Always consult a healthcare professional.

TVPills is independent and not affiliated with, endorsed by, or sponsored by any drug manufacturer or brand. All trademarks are the property of their respective owners. Some links are affiliate links; we may earn a commission at no extra cost to you.